Skip to content
Dan

Dan

Founder, Blueshot

Founder of Blueshot. Writes GLP-1 medication guides grounded in primary clinical sources (NEJM, JAMA, FDA labels) and real Korean/US pricing.

Articles

Generic Saxenda in Korea: How the Liraglutide Copy Story Really Lands
Medication Guide

Generic Saxenda in Korea: How the Liraglutide Copy Story Really Lands

The FDA cleared a Victoza-referenced liraglutide generic on December 23, 2024, and Biocon announced gSaxenda approval on February 24, 2026. Korea has the licensing deal — but 'generic approved' and 'cheaper shot this month' are not the same sentence.

15 min read·
Read more
Are Zepbound and Mounjaro the same drug? Same tirzepatide, different U.S. labels
Medication Guide

Are Zepbound and Mounjaro the same drug? Same tirzepatide, different U.S. labels

They share tirzepatide, the same weekly dosing ladder, and a lot of the same side-effect logic. In the U.S., though, Zepbound is the obesity brand and Mounjaro is the diabetes brand, which changes coverage, cash-pay pages, and even the right search term.

14 min read·
Read more
Wegovy side effects in 2026: what's normal, what's not
Medication Guide

Wegovy side effects in 2026: what's normal, what's not

Nausea is common. Sudden severe belly pain, dehydration, or sudden vision loss are not. Here's what Wegovy side effects usually feel like, which ones are actual red flags, and what changed in the latest FDA and EMA safety updates.

11 min read·
Read more
Wegovy Pill vs. Wegovy Shot in 2026: Cost, Dosing, Weight Loss, and Where Zepbound Fits
Medication Guide

Wegovy Pill vs. Wegovy Shot in 2026: Cost, Dosing, Weight Loss, and Where Zepbound Fits

Oral Wegovy is not a rumor anymore in the U.S. It is a real daily tablet with a very different price ladder, dosing schedule, and switching logic than the weekly shot. Here is the clean comparison for 2026, including why U.S. readers should say Zepbound, not Mounjaro, when they mean the tirzepatide obesity injection.

13 min read·
Read more
Wegovy vs. Zepbound: Which One Makes More Sense in 2026?
Medication Guide

Wegovy vs. Zepbound: Which One Makes More Sense in 2026?

A US-first comparison of Wegovy and Zepbound covering weight-loss data, side effects, coverage, cost, and the practical differences that matter once you move past the headline percentages.

12 min read·
Read more
Foundayo in 2026: the new GLP-1 pill that skips fasting rules
News

Foundayo in 2026: the new GLP-1 pill that skips fasting rules

Foundayo got FDA approval on April 1, 2026. It is a once-daily oral GLP-1 that can be taken with or without food and without water restrictions. Here is what the U.S. label, ATTAIN trials, and pricing lanes actually say.

9 min read·
Read more
How Much Wegovy Costs in Korea in 2026
Medication Guide

How Much Wegovy Costs in Korea in 2026

In Korea, Wegovy does not have one simple monthly price. The real number depends on dose, clinic fees, and how long you've been on treatment. Here is the cleanest way to budget for it in 2026.

9 min read·
Read more